Gordon LG, Mayne GC, Hirst NG, Bright T, Whiteman DC, Watson DI, et al. Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagus. Gastrointest Endosc 2014 Feb 1;79(2):242-56 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/24079411.
Compare quality appraisals for each clinical question
- Is surveillance cost-effective for follow-up of patients with BO?
- What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?
- Are there groups of patients with non-dysplastic BO that require more frequent surveillance?
- Are there groups of patients with BO that can be discharged from surveillance?